Table 5.

Overall comparative zones of inhibition patterns and profiles of the diarrhoeagenic bacterial species towards the expired and unexpired paediatric antibiotics

Bacterial species	Type	% Zones of inhibition profiles
E. coli	E	10.0 [115], 11.0 [19], 12.0 [29], 13.0 [37], 14.0 [18], 15.0 [39], 16.0 [13], 17.0 [7], 18.0 [20], 19.0 [23], 20.0 [33], 21.0 [9], 22.0 [8], 23.0 [11], 24 [5], 25.0 [12 (2.9%)], 26.0 [2 (0.5%)], 27.0 [3 (0.7%)], 28.0 [1 (0.2%)], 29.0 [2 (0.5%)], 30.0 [2 (0.5%)], 33.0 [1 (0.2%)] ≥ 25.0 [23 (5.6%)] S [409 (30.7%)] / R [924 (69.3%)]
	U	10.0 [80], 11.0 [19], 12.0 [9], 13.0 [7], 14.0 [7], 15.0 [9], 16.0 [5], 17.0 [11], 18.0 [7], 19.0 [15], 20.0 [21], 21.0 [6], 22.0 [7], 23.0 [10], 24 [1], 25.0 [13 (5.0%)], 26.0 [2 (0.8%)], 27.0 [8 (3.1%)], 28.0 [5 (1.9%)], 29.0 [7 (2.7%)], 30.0 [3 (1.2%)], 33.0 [1 (0.4%)] ≥ 25.0 [39 (15.0%)]* S [260 (86.4%)] /R [41 (13.6%)]
Kleb. Pneumoniae	E	10.0 [35], 11.0 [7], 12.0 [3], 13.0 [7], 14.0 [2], 15.0 [17], 16.0 [7], 17.0 [7], 18.0 [7], 19.0 [6], 20.0 [21], 21.0 [2], 22.0 [4], 23.0 [3], 24.0 [3], 25.0 [7 (4.9%)], 26.0 [1 (0.7%)], 28.0 [1 (0.7%)], 29.0 [2 (1.4%)], 30.0 [1 (0.7%)], 33.0 [1 (0.7%)] ≥ 25.0 [13 (9.0%)] S [144 (29.0%)] /R [352 (71.0%)]
	U	10.0 [31], 11.0 [6], 13.0 [5], 14.0 [3], 15.0 [8], 16.0 [2], 19.0 [8], 20.0 [4], 22.0 [5], 23.0 [2], 24 [1], 25.0 [4 (4.3%)], 26.0 [1 (1.1%)], 27.0 [3 (3.2%)], 28.0 [4 (4.3%)], 29.0 [2 (2.2%)], 30.0 [4 (4.3%)] ≥ 25.0 [18 (18.4%)]* S [93 (83.0%)] /R [19 (17.0%)]
Pr. mirabilis	E	10.0 [28], 11.0 [8], 12.0 [6], 13.0 [11], 14.0 [5], 15.0 [8], 16.0 [5], 17.0 [2], 18.0 [2], 19.0 [4], 20.0 [33], 21.0 [6], 22.0 [2], 23.0 [2], 24 [1], 25.0 [4 (3.0%)], 26.0 [1 (0.75%)], 28.0 [2 (1.5%)], 29.0 [1 (0.75%)], 30.0 [1 (0.75%)], 35.0 [1 (0.75%)] ≥ 25.0 [10 (7.5%)] S [133 (35.8%)] /R [239 (64.2%)]
	U	10.0 [12], 11.0 [3], 12.0 [1], 13.0 [4], 14.0 [2], 15.0 [4], 15.0 [4], 16.0 [1], 17.0 [3], 18.0 [2], 19.0 [4], 20.0 [5], 21.0 [2], 22.0 [1], 23.0 [1], 25.0 [2 (3.4%)], 27.0 [5 (8.6%)], 28.0 [1 (1.7%)], 29.0 [3 (5.2%)], 30.0 [1 (1.7%)] ≥ 25.0 [12 (20.7%)]* S [58 (69.0%)] /R [26 (31.0%)]
Staph. aureus	E	10.0 [26], 12.0 [5], 13.0 [10], 14.0 [5], 15.0 [9], 16.0 [10], 17.0 [1], 18.0 [7], 19.0 [1], 20.0 [5], 21.0 [2], 23.0 [2], 24.0 [2], 25.0 [4 (4.3%)], 26.0 [1 (1.1%)], 27.0 [1 (1.1%)], 29.0 [2 (2.2%)], 30.0 [1 (1.1%)] ≥ 25.0 [9 (9.7%)] S [93 (27.3%)] /R [248 (72.7%)]
	U	10.0 [21], 11.0 [2], 12.0 [1], 13.0 [3], 14.0 [1], 15.0 [4], 16.0 [4], 17.0 [4], 18.0 [3], 19.0 [6], 20.0 [5], 22.0 [1], 23.0 [1], 24 [3], 25.0 [2 (2.8%)], 26.0 [1 (1.4%)], 27.0 [3 (4.2%)], 29.0 [1 (1.4%)], 30.0 [1 (1.4%)] ≥ 25.0 [8 (11.1%)]* S [72 (93.5%)] /R [5 (6.5%)]
Lactobacillus spp.	E	10.0 [18], 11.0 [5], 12.0 [4], 13.0 [5], 14.0 [4], 15.0 [6], 16.0 [5], 17.0 [2], 18.0 [2], 19.0 [2], 20.0 [6], 21.0 [2], 22.0 [2], 23.0 [3], 24 [1], 25.0 [5 (6.2%)], 26.0 [5 (6.2%)], 27.0 [1 (1.2%)], 28.0 [1 (1.2%)], 30.0 [3 (3.7%)] ≥ 25.0 [15 (18.5%)]* S [81 (32.7%)] / R [167 (67.3%)]
	U	10.0 [10], 11.0 [5], 12.0 [2], 13.0 [1], 14.0 [1], 15.0 [7], 16.0 [4], 17.0 [5], 18.0 [1], 19.0 [2], 20.0 [1], 24 [1], 25.0 [3 (5.6%)], 27.0 [1 (1.9%)], 29.0 [1 (1.9%)], 30.0 [3 (5.6%)], 33.0 [1 (1.9%)] ≥ 25.0 [9 (16.7%)] S [54 (96.4%)] / R [2 (3.6%)]

Keys: 1=Throtal (erythromycin); 3=Zinnat (cefuroxime axetil); 4=Tambac (cefpodoxime proxetil); 5=Bactrim (sulfamethoxazole + trimethoprim); 7 Loxaprim (co-trimoxazole); 8 Refucil (griseofulvin); 10 Loxagyl (metronidazole), 25=(erythromycin); E=expired; U=unexpired.

^*Higher rates of widest zones of inhibitions